Search for: "Anda Pharmaceuticals, Inc" Results 201 - 220 of 605
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Apr 2014, 9:59 pm by Patent Docs
In this Hatch-Waxman litigation, the plaintiffs (patent owners and licensees) brought suit after the defendants filed an ANDA with a paragraph IV certification alleging that the claims of plaintiffs' patent 5,721,244 ("'244 patent") were obvious. [read post]
13 Apr 2014, 9:43 pm by Patent Docs
Reddy's Laboratories Inc. [read post]
7 Apr 2014, 9:59 pm by Patent Docs
The case involved patentee Senju Pharmaceutical's (joined by Kyorin Pharmaceutical Co. and Allergan, Inc.) suit against Apotex in response to a Paragraph IV certification against Senju's patented ocular antimicrobial agent containing the drug Gatifloxacin as claimed in U.S. [read post]
4 Apr 2014, 9:32 am by Gene Quinn
On March 19, 2014, Actavis plc (NYSE: ACT) announced that it entered into an agreement with Noven Pharmaceuticals, Inc. to settle all outstanding patent litigation related to Actavis’ generic version of Daytrana® (Methylphenidate Transdermal System). [read post]
1 Apr 2014, 7:17 pm
     Procedural HistoryPlaintiffs- Appellants Senju Pharmaceutical Co., Ltd., Kyorin Phar- maceutical Co., Ltd., and Allergan, Inc. [read post]
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE;… [read post]
13 Feb 2014, 9:04 am
According to the complaint, the Cipla entities are engaged in the generic-pharmaceutical business. [read post]
9 Feb 2014, 9:15 pm by Patent Docs
Reddy's Laboratories Inc. [read post]
12 Jan 2014, 6:36 pm by Patent Docs
.; Micro Labs USA Inc. [read post]
9 Jan 2014, 6:08 am by Aaron Barkoff
Supernus Pharmaceuticals, Inc., IPR2013-00368, IPR2013-00371, IPR2013-00372 (PTAB)     by Robert F. [read post]